Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first regulatory approval of a therapy for these patients in more than...
Read moreFinerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first regulatory approval of a therapy for these patients in more than...
Read moreRuth CleggHealth and wellbeing reporterAlamyIt's the body's superhighway that carries information from your brain to your major organs. You might not have a clue it exists - let alone that...
Read more(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/118382 Author : Publish date : 2025-11-08 22:00:00 Copyright for syndicated...
Read more(MedPage Today) -- NEW ORLEANS -- A direct oral anticoagulant (DOAC) was unable to further lower the risk of atrial fibrillation (Afib or AF) patients a year or more after...
Read more(MedPage Today) -- HOUSTON -- Chronic kidney disease (CKD) took the ninth spot on the leading causes of death globally in 2023. By 2023, 788 million people ages 20 years...
Read moreSubstantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but validation in further studies is still needed. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fish-oil-shows-cardiovascular-benefits-dialysis-patients-2025a1000uze?src=rss Author :...
Read more(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president...
Read moreAn AI-powered app can turn a smartwatch into a predictor of structural heart disease, a new study finds. Medscape Medical News Source link : https://www.medscape.com/viewarticle/app-turns-smartwatch-detector-structural-heart-disease-2025a1000uzc?src=rss Author : Publish date :...
Read more(MedPage Today) -- In August, the Trump administration announced a major initiative urging medical schools and medical-education organizations to implement "comprehensive nutrition education and training" as part of its Make...
Read more(MedPage Today) -- NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that was unresponsive to lipid-lowering therapy, according to...
Read more‘A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C. Medscape Medical News Source link : https://www.medscape.com/viewarticle/navigating-skin-related-variants-lupus-2025a1000uz8?src=rss Author : Publish date :...
Read more(MedPage Today) -- HOUSTON -- SGLT2 inhibitors may hold a benefit for a wider pool of patients with chronic kidney disease (CKD) than previously thought, a pair of meta-analyses indicated....
Read more(MedPage Today) -- Doctor after doctor misdiagnosed or shrugged off Ruth Wilson's rashes, swelling, fevers, and severe pain for 6 years. She saved her life by begging for one more...
Read more(MedPage Today) -- NEW ORLEANS -- An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed. One Chinese cohort had triglycerides slashed from...
Read more(MedPage Today) -- ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy,...
Read moreIncreased exposure to artificial light at night is linked to higher stress-related activity in the brain, more inflammation in the arteries, and an increased risk for heart disease. Medscape Medical...
Read moreLaura KuenssbergPresenter, Sunday with Laura KuenssbergBBCWarning - this story contains distressing content and discussion of suicideMegan Garcia had no idea her teenage son Sewell, a "bright and beautiful boy", had...
Read moreNick TriggleHealth correspondentGetty ImagesGP Dr David Turner no longer sees patients on a Wednesday morning.Instead, he spends that time sifting through the online appointment requests to work out what each...
Read more(MedPage Today) -- A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in a phase III trial died, Intellia Therapeutics said. The news came...
Read more(MedPage Today) -- Patients newly diagnosed with advanced breast cancer in 2025 would be expected to live 7 months longer on average than they did 15 years ago, according to...
Read more© 2022 NewsHealth.
© 2022 NewsHealth.